224 related articles for article (PubMed ID: 8695019)
1. Reduction of development of left ventricular hypertrophy in salt-loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition.
de Simone G; Devereux RB; Camargo MJ; Wallerson DC; Sealey JE; Laragh JH
Am J Hypertens; 1996 Mar; 9(3):216-22. PubMed ID: 8695019
[TBL] [Abstract][Full Text] [Related]
2. Midwall left ventricular performance in salt-loaded Dahl rats: effect of AT1 angiotensin II inhibition.
de Simone G; Devereux RB; Camargo MJ; Wallerson DC; Sealey JE; Laragh JH
J Hypertens; 1995 Dec; 13(12 Pt 2):1808-12. PubMed ID: 8903657
[TBL] [Abstract][Full Text] [Related]
3. AT1 receptor antagonist, TCV 116, does not prevent cardiac hypertrophy in salt-loaded Dahl salt-sensitive rats.
Sugimoto K; Gotoh E; Takasaki I; Ebina T; Iwamoto T; Takizawa T; Shionoiri H; Ishii M
Clin Exp Pharmacol Physiol; 1996 Apr; 23(4):282-6. PubMed ID: 8717062
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonist markedly reduces mortality in salt-loaded Dahl S rats.
von Lutterotti N; Camargo MJ; Mueller FB; Timmermans PB; Laragh JH
Am J Hypertens; 1991 Apr; 4(4 Pt 2):346S-349S. PubMed ID: 1854463
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
Nagura J; Yamamoto M; Hui C; Yasuda S; Hachisu M; Konno F
Clin Exp Pharmacol Physiol; 1996 Mar; 23(3):229-35. PubMed ID: 8934613
[TBL] [Abstract][Full Text] [Related]
7. [Losartan and the LIFE-study. Antihypertensive treatment with AT1-receptor antagonist].
Kjeldsen SE; Omvik P
Tidsskr Nor Laegeforen; 1996 Feb; 116(4):504-7. PubMed ID: 8644056
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats.
von Lutterotti N; Camargo MJ; Campbell WG; Mueller FB; Timmermans PB; Sealey JE; Laragh JH
J Hypertens; 1992 Sep; 10(9):949-57. PubMed ID: 1328376
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen gas improves left ventricular hypertrophy in Dahl rat of salt-sensitive hypertension.
Matsuoka H; Miyata S; Okumura N; Watanabe T; Hashimoto K; Nagahara M; Kato K; Sobue S; Takeda K; Ichihara M; Iwamoto T; Noda A
Clin Exp Hypertens; 2019; 41(4):307-311. PubMed ID: 29902079
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
11. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
[TBL] [Abstract][Full Text] [Related]
12. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II.
Gahnem F; Camargo MJ; von Lutterotti N; Laragh JH; Sealey JE
J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857
[TBL] [Abstract][Full Text] [Related]
13. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
[TBL] [Abstract][Full Text] [Related]
14. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade.
Leenen FH; Yuan B
Hypertension; 2001 Mar; 37(3):981-4. PubMed ID: 11244027
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of losartan on blood pressure and left ventricular structure in essential hypertension.
Himmelmann A; Svensson A; Bergbrant A; Hansson L
J Hum Hypertens; 1996 Nov; 10(11):729-34. PubMed ID: 9004102
[TBL] [Abstract][Full Text] [Related]
16. Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients.
Klingbeil AU; Müller HJ; Delles C; Fleischmann E; Schmieder RE
Am J Hypertens; 2000 Dec; 13(12):1295-300. PubMed ID: 11130774
[TBL] [Abstract][Full Text] [Related]
17. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
[TBL] [Abstract][Full Text] [Related]
18. Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA).
Malmqvist K; Kahan T; Edner M; Bergfeldt L
Am J Cardiol; 2002 Nov; 90(10):1107-12. PubMed ID: 12423712
[TBL] [Abstract][Full Text] [Related]
19. Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
Liang B; Leenen FH
J Cardiovasc Pharmacol; 2008 May; 51(5):457-66. PubMed ID: 18418273
[TBL] [Abstract][Full Text] [Related]
20. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
